Literature DB >> 2313297

Simultaneous VEP and PERG investigations in early Parkinson's disease.

S Calzetti1, A Franchi, G Taratufolo, E Groppi.   

Abstract

To evaluate whether visual evoked potential (VEP) and pattern electroretinogram (PERG) abnormalities may be detectable early in the course of Parkinson's disease (PD) and to assess a possible interdependence between retinal and cortical potentials, simultaneous VEP and PERG were carried out in nine patients with early PD. The mean (SD) duration of the disease was 10 (6) months. None of the patients had been previously treated with levodopa or other anti-parkinsonian drugs. The results show VEP and PERG abnormalities that are spatial stimulus dependent, with higher frequencies being more involved and also indicate that VEP changes are not entirely dependent on alterations at the retinal level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2313297      PMCID: PMC487947          DOI: 10.1136/jnnp.53.2.114

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans.

Authors:  M Onofrj; M F Ghilardi; M Basciani; D Gambi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

Review 2.  Steady-state evoked potentials.

Authors:  D Regan
Journal:  J Opt Soc Am       Date:  1977-11

3.  The role of the retinal interplexiform cell: effects of 6-hydroxydopamine on the spatial properties of carp horizontal cells.

Authors:  J L Cohen; J E Dowling
Journal:  Brain Res       Date:  1983-04-04       Impact factor: 3.252

4.  Comparison of transient and steady-state methods.

Authors:  D Regan
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

5.  Measurements of visual evoked potentials in Parkinson's disease.

Authors:  I Bodis-Wollner; M D Yahr
Journal:  Brain       Date:  1978-12       Impact factor: 13.501

6.  Uptake and efflux of 14-C-dopamine in platelets: evidence for a generalized defect in Parkinson's disease.

Authors:  A Barbeau; G Campanella; R F Butterworth; K Yamada
Journal:  Neurology       Date:  1975-01       Impact factor: 9.910

7.  Visual system abnormalities in patients with Parkinson's disease.

Authors:  M J Kupersmith; E Shakin; I M Siegel; A Lieberman
Journal:  Arch Neurol       Date:  1982-05

8.  Regulatory effect of dopamine on spatial properties of horizontal cells in carp retina.

Authors:  T Teranishi; K Negishi; S Kato
Journal:  J Neurosci       Date:  1984-05       Impact factor: 6.167

9.  Pattern evoked potentials (PEPs) in Parkinson's disease.

Authors:  D S Dinner; H Lüders; M Hanson; R P Lesser; G Klem
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

10.  Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model.

Authors:  M F Ghilardi; I Bodis-Wollner; M C Onofrj; M S Marx; A A Glover
Journal:  Brain       Date:  1988-02       Impact factor: 13.501

View more
  6 in total

Review 1.  Retinal melatonin and dopamine in seasonal affective disorder.

Authors:  D A Oren
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Visual hallucinosis: the major clinical determinant of distorted chromatic contour perception in Parkinson's disease.

Authors:  T Büttner; W Kuhn; T Müller; F L Welter; J Federlein; K Heidbrink; H Przuntek
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.

Authors:  Garrett E Alexander
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

4.  Clinical factors affecting evoked magnetic fields in patients with Parkinson's disease.

Authors:  Ryoji Naganuma; Ichiro Yabe; Megumi Takeuchi; Kirari Morishita; Shingo Nakane; Ryoken Takase; Ikuko Takahashi-Iwata; Masaaki Matsushima; Mika Otsuki; Hideaki Shiraishi; Hidenao Sasaki
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

5.  Exploring Bottom-Up Visual Processing and Visual Hallucinations in Parkinson's Disease With Dementia.

Authors:  Nicholas Murphy; Alison Killen; Rajnish Kumar Gupta; Sara Graziadio; Lynn Rochester; Michael Firbank; Mark R Baker; Charlotte Allan; Daniel Collerton; John-Paul Taylor; Prabitha Urwyler
Journal:  Front Neurol       Date:  2021-01-28       Impact factor: 4.003

6.  Interocular asymmetry of foveal thickness in Parkinson disease.

Authors:  Eric M Shrier; Christopher R Adam; Brian Spund; Sofya Glazman; Ivan Bodis-Wollner
Journal:  J Ophthalmol       Date:  2012-08-01       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.